Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Expenditure on medical devices in Italy: report published by the Ministry of Health

01 Mar 2018

The analysis showed that the expenditure on medical devices (i.e., medical devices, active implantable medical devices, and in vitro diagnostic devices) in 2016 increased of 1.4% compared to 2015. The highest figure was registered for implantable medical devices (+3.7%).

The Regions with the highest volumes were Lombardia (EUR 599,008,730), Veneto (EUR 420,105,473), Emilia Romagna (EUR 394,547,901), and Toscana (EUR 378,124,997).

The top 4 classes of medical devices, accounting for 51.6% of the total expenditure in 2016, were the following:

  • Prosthetic implantable devices and osteosynthesis products: 20.8% of the total (+4.6% compared to 2015). Within this class, 85.6% were orthopaedic prostheses (49.4%) and vascular and cardiac prostheses (36.2%).
  • Devices for the cardiocirculatory apparatus: 12.1% of the total (+5.8% compared to 2015). Within this class, 80% were arterio-venous devices (54.2%), arrhythmology devices (13.2%), and guide-wires (12%).
  • Active implantable devices: 9.8% of the total (+5% compared to 2015). Within this class, 86.6% were devices for the cardiac functions.
  • Devices for administration and collection: 8.9% of the total (+9.4% compared to 2015). Within this class, 69% were conduits and tubes (30.4%), needles (22.6%), and liquid collection devices (15.9%).

See the report in Italian here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.